MUMS the word: Medically underwritten mortality studies' benefit questioned

Getty Images

Analysis: Medical underwriting of defined benefit scheme members to facilitate bulk annuity insurance transactions has taken off over the past two years, but industry experts are sceptical of the benefits of using medical data for scheme valuations.

Register now for FREE to read this article

If you are already a registered you can SIGN IN now

Register today for free!

It’s quick and easy, and as a registered user you’ll have full access to all Pension Expert articles. You will also be able to recieve editorial emails.

  • Full access to all news, analysis and expert comment
  • The latest industry insights delivered to your inbox on a Tuesday and Thursday morning
  • The Friday Takeaway newsletter reviewing the major events of the week
  • Bookmark your favourite articles for easy review
  • Hear about and register to attend Pensions Expert and DG Publishing events